Is neuroendocrine cell differentiation detected using chromogranin a from patients with bone metastatic prostate cancer a prognostic factor for outcome?

Yoshiaki Yamada, Kogenta Nakamura, Shigeyuki Aoki, Tomohiro Taki, Hiroyuki Matsubara, Shotoku Sai, Katsuya Naruse, Motoi Tobiume, Remi Katsuda, Kenji Zennami, Nobuaki Honda, Atsuko Nakagawa, Hiroshi Ikeda

Research output: Contribution to journalArticlepeer-review

7 Citations (Scopus)

Abstract

We evaluated the usefulness of overexpression of neuroendrocrine (NE) cell differentiation determined by immunohistochemical staining for chromogranin A (Cg A) in diagnostic needle biopsy specimens of bone metastatic prostate cancers. A total of 50 patients diagnosed as having bone metastatic prostate cancer were studied. The period of observation was between 6.9 and 79.4 months (median 48.7 months). Cg A was detected by immunostaining using the labeled streptavidin biotin method. Cg A-positivity was defined as the presence of immunostained cells in 10% or more of the tumor. All statistical analyses were carried out using the Statistical Package for Social Sciences Software, version 10.0 for Windows. Eleven patients (22%) were classified into the Cg A-positive group. There were no significant differences in clinical data between the Cg A-positive and Cg A-negative groups. The 5-year cause-specific survival rate was 34.1% for the Cg A-positive group and 55.2% for the Cg A-negative group (p=0.3763). The 3-year non-recurrence rate was 9.1% for the Cg A-positive group and 35.9% for the Cg A-negative group, and this difference was significant (p=0.0253). The 3-year cause-specific survival rates after recurrence were 38.4% and 42.3% respectively (p=0.8125). We consider that NE cell differentiation of the primary tumor in cases of bone metastatic prostate cancer is not a prognostic factor for outcome.

Original languageEnglish
Pages (from-to)1309-1313
Number of pages5
JournalOncology reports
Volume15
Issue number5
DOIs
Publication statusPublished - 05-2006
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Is neuroendocrine cell differentiation detected using chromogranin a from patients with bone metastatic prostate cancer a prognostic factor for outcome?'. Together they form a unique fingerprint.

Cite this